Ausgabe 1/2022
Inhalt (23 Artikel)
Influence of extracellular volume fraction on peak exercise oxygen pulse following thoracic radiotherapy
Justin M. Canada, Elisabeth Weiss, John D. Grizzard, Cory R. Trankle, Leila Rezai Gharai, Franklin Dana, Leo F. Buckley, Salvatore Carbone, Dinesh Kadariya, Anthony Ricco, Jennifer H. Jordan, Ronald K. Evans, Ryan S. Garten, Benjamin W. Van Tassell, W. Gregory Hundley, Antonio Abbate
Bridging the gap to advance the care of individuals with cancer: collaboration and partnership in the Cardiology Oncology Innovation Network (COIN)
Sherry-Ann Brown, Craig Beavers, Hugo R. Martinez, Catherine H. Marshall, Iredia M. Olaye, Avirup Guha, David Cho, Alison Bailey, Carmen Bergom, Neha Bansal, Brenton Bauer, Richard K. Cheng
Cardiotoxicity risk factors with immune checkpoint inhibitors
Zachary L. Brumberger, Mary E. Branch, Max W Klein, Austin Seals, Michael D. Shapiro, Sujethra Vasu
Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational study
Youquan Li, Whee Sze Ong, Ma Than Than Shwe, Nelson Ling Fung Yit, Sheriff Zhan Hong Quek, Eric Pei Ping Pang, Wen Shen Looi, Wen Long Nei, Michael Lian Chek Wang, Melvin Lee Kiang Chua, Terence Wee Kiat Tan, Eu Tiong Chua, Choon Ta Ng, Jeffrey Kit Loong Tuan
Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis
Jiandong Zhou, Sharen Lee, Ishan Lakhani, Lei Yang, Tong Liu, Yuhui Zhang, Yunlong Xia, Wing Tak Wong, Kelvin King Hei Bao, Ian Chi Kei Wong, Gary Tse, Qingpeng Zhang
CD-19 CART therapy and orthostatic hypotension: a single center retrospective cohort study
Ashish Patel, Joshua Levenson, Ziyu Huang, Mounzer Agha, Kathleen Dorritie
Mediastinal irradiation and valvular heart disease
Shivaraj Patil, Srinath-Reddi Pingle, Khalid Shalaby, Agnes S. Kim
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Rhys I. Beaudry, Mark J. Haykowsky, James P. MacNamara, Wesley J. Tucker, Roshni Rao, Barbara Haley, Satyam Sarma
Proton beam therapy causing pericarditis – a rare case of radiation induced cardiotoxicity
Rahul Gupta, Muling Lin, Gary M. Freedman, Deborah W. Sundlof, Cheri Silverstein Fadlon
Comprehensive molecular characterization of hypertension-related genes in cancer
Yanan Jiang, Chunpeng Shi, Songyu Tian, Fengnan Zhi, Xiuyun Shen, Desi Shang, Jinwei Tian
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Arash Delavar, Catherine Boutros, Dana Barnea, Wendy L. Schaffer, Emily S. Tonorezos
Atrial fibrillation in cancer patients who develop stroke
Alia Khamis, Ala Emad Shaban, Tamer Salhab Altamimi, Zakaria Walid Shkoukani, Ismail Hamam
Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports
Michael S. Ewer, Jay Herson
Early access to a cardio-oncology clinic in an Australian context: a qualitative exploration of patient experiences
Jennifer White, Julie Byles, Trent Williams, Rossana Untaru, Doan T. M. Ngo, Aaron L. Sverdlov
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Arash Delavar, Catherine Boutros, Dana Barnea, Wendy L. Schaffer, Emily S. Tonorezos
A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research
Cameron Brown, Michael Mantzaris, Elpiniki Nicolaou, Georgia Karanasiou, Elisavet Papageorgiou, Giuseppe Curigliano, Daniela Cardinale, Gerasimos Filippatos, Nikolaos Memos, Katerina K. Naka, Andri Papakostantinou, Paris Vogazianos, Erietta Ioulianou, Christos Shammas, Anastasia Constantinidou, Federica Tozzi, Dimitrios I. Fotiadis, Athos Antoniades
Echocardiographic strategy for early detection of cardiotoxicity of doxorubicin: a prospective observational study
Diogo Pereira Santos Sampaio, João Batista Masson Silva, Daniela do Carmo Rassi, Aguinaldo F. Freitas Jr, Salvador Rassi
Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma
Julius C. Heemelaar, Jeroen Janson, Jerry Braun, Frank M. Speetjens, Michiel A. J. van de Sande, Juan D. V. Hugo, Daniela Q. C. M. Barge-Schaapveld, Saskia L. M. A. Beeres, Laurens F. Tops, Hans Gelderblom, M. Louisa Antoni
Exercise-induced Brugada pattern and ventricular tachycardia during Capecitabine treatment
George B. Strobel, Shiva P. Ponamgi, Attila Roka, Ahmed S. A. Aboeata
Outcomes of malignancy in adults with congenital heart disease: a single center experience
Prashanth Venkatesh, Kimberly L. Yan, Katia Bravo-Jaimes, Eric H. Yang, Gentian Lluri
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment
Maria Sol Andres, Sivatharshini Ramalingam, Stuart D. Rosen, John Baksi, Rajdeep Khattar, Yulia Kirichenko, Kate Young, Nadia Yousaf, Alicia Okines, Robert Huddart, Kevin Harrington, Andrew J.S. Furness, Samra Turajlic, Lisa Pickering, Sanjay Popat, James Larkin, Alexander R. Lyon
Acute ST-segment elevations following paclitaxel administration for uterine cervical cancer: a case report and literature review
Shota Higami, Yusuke Tanaka, Tomomi Deguchi, Mariko Shiraishi, Yasuhiko Shiki
Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study
Charlie Wang, Sophia Zoungas, Mabel Yan, Rory Wolfe, Andrew Haydon, Mark Shackleton, Mark Voskoboynik, Maggie Moore, Miles C. Andrews, Stephen J. Nicholls, Victoria Mar